EUVIMEDEUVIMED entdecken
Crossref

TRIM26‐Mediated CBX6 Ubiquitination Triggers NETosis to Drive Bladder Cancer Tumor Growth via the CNPY2/NF‐κB Signaling Pathway

XiaoJuan Xie, ZhenZhen Li, TongTong Qiu iD, HuiJin Li, Qiaodi Gui iD

Drug Development Research · 2026

DOI: 10.1002/ddr.70316 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Development Research, 2026. Verfasst von XiaoJuan Xie und 4 weiteren Autor:innen. Beteiligte Einrichtung: Shaanxi Center for Clinical Laboratory, Shaanxi Provincial People's Hospital, Xi'an, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Tripartite Motif Proteins, Ubiquitin-Protein Ligases, Polycomb Repressive Complex 1. Die Arbeit nennt 58 Literaturangaben. Gefördert von: Scientific and Technological Talents Support Program of Shaanxi Provincial People's Hospital in China, Basic Research Program of Natural Science Foundation of Shaanxi Province in China, Innovation Promotion Initiative Technology Team of Shaanxi Province in China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neutrophil extracellular traps (NETs) play a critical role in bladder cancer (BCa) progression, but the intrinsic molecular drivers within tumor cells that orchestrate NET formation remain largely unknown. This study aimed to investigate whether and how the E3 ubiquitin ligase TRIM26 influences BCa malignancy by regulating NET formation. Analysis of public cohort data revealed a significant positive correlation between TRIM26 expression and neutrophil infiltration in BCa, which was confirmed in our clinical samples showing markedly enhanced neutrophil infiltration and NET formation in tumor tissues compared with adjacent normal tissues. Functional assays demonstrated that NETs promoted BCa cell proliferation, migration, invasion, and epithelial‐mesenchymal transition in a TRIM26‑dependent manner. Mechanistically, TRIM26 directly bound to Chromobox 6 (CBX6) and mediated its ubiquitination and degradation. CBX6 transcriptionally represses canopy FGF signaling regulator 2 (CNPY2) by catalyzing H2AK119ub1 deposition on its promoter. Degradation of CBX6 led to CNPY2 upregulation, which activated the NF‑κB pathway and stimulated IL‑8 secretion. Secreted IL‑8 recruited neutrophils and induced NET formation, establishing a positive feedback loop that fuels tumor progression. In vivo experiments confirmed that disrupting NETs with DNase I significantly inhibited TRIM26 overexpression‑driven tumor growth and metastasis. Collectively, this study uncovers a TRIM26/CBX6/CNPY2 signaling axis that drives NET formation via the NF‐κB/IL‐8 pathway to promote BCa progression, providing novel mechanistic insights and potential therapeutic targets for combating NET‐driven BCa malignancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsTripartite Motif ProteinsUbiquitin-Protein LigasesPolycomb Repressive Complex 1HumansUbiquitinationAnimalsNF-kappa BSignal TransductionCell ProliferationCell Line, TumorMiceMice, NudeMaleFemaleMice, Inbred BALB C

Stichwörter der Autor:innen

CNPY2TRIM26bladder cancerneutrophil extracellular traps (NETs)ubiquitination

Substanzen

NF-kappa BTripartite Motif ProteinsUbiquitin-Protein LigasesPolycomb Repressive Complex 1

Autor:innen und Institutionen

  • Shaanxi Center for Clinical Laboratory, Shaanxi Provincial People's Hospital, Xi'an, China.
  • Pathology Department, Shaanxi Provincial People's Hospital, Xi'an, China.
  • Department of Clinical Laboratory, Shaanxi Provincial People's Hospital, Xi'an, China.
  • Institute of Basic and Translational Medicine, Xi'an Medical University, Xi'an, China.

ORCID-Profile: TongTong Qiu, Qiaodi Gui

Förderung

  • Scientific and Technological Talents Support Program of Shaanxi Provincial People's Hospital in China
  • Basic Research Program of Natural Science Foundation of Shaanxi Province in China
  • Innovation Promotion Initiative Technology Team of Shaanxi Province in China

Zitieren

APA

Xie, X., Li, Z., Qiu, T., Li, H., & Gui, Q. (2026). TRIM26‐Mediated CBX6 Ubiquitination Triggers NETosis to Drive Bladder Cancer Tumor Growth via the CNPY2/NF‐κB Signaling Pathway. Drug Development Research. https://doi.org/10.1002/ddr.70316

Vancouver

Xie X, Li Z, Qiu T, Li H, Gui Q. TRIM26‐Mediated CBX6 Ubiquitination Triggers NETosis to Drive Bladder Cancer Tumor Growth via the CNPY2/NF‐κB Signaling Pathway. Drug Development Research. 2026. doi:10.1002/ddr.70316

BibTeX
@article{Xie2026,
  author = {Xie, XiaoJuan and Li, ZhenZhen and Qiu, TongTong and Li, HuiJin and Gui, Qiaodi},
  title = {TRIM26‐Mediated CBX6 Ubiquitination Triggers NETosis to Drive Bladder Cancer Tumor Growth via the CNPY2/NF‐κB Signaling Pathway},
  journal = {Drug Development Research},
  year = {2026},
  doi = {10.1002/ddr.70316}
}
Kostenlos starten →